These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 11206597

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
    Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM.
    J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
    [Abstract] [Full Text] [Related]

  • 3. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
    Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R.
    Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.
    Sheikh JI, Londborg P, Clary CM, Fayyad R.
    Int Clin Psychopharmacol; 2000 Nov; 15(6):335-42. PubMed ID: 11110009
    [Abstract] [Full Text] [Related]

  • 8. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ.
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [Abstract] [Full Text] [Related]

  • 9. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
    Lepola U, Arató M, Zhu Y, Austin C.
    J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early coadministration of clonazepam with sertraline for panic disorder.
    Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D.
    Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G, Rosenbaum JF.
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [Abstract] [Full Text] [Related]

  • 13. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, Lebeau RT, Moshier SJ, Zalta AK, Pollack MH.
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [Abstract] [Full Text] [Related]

  • 14. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
    Bandelow B, Behnke K, Lenoir S, Hendriks GJ, Alkin T, Goebel C, Clary CM.
    J Clin Psychiatry; 2004 Mar; 65(3):405-13. PubMed ID: 15096081
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan.
    Kamijima K, Kuboki T, Kumano H, Burt T, Cohen G, Arano I, Hamasaki T.
    Int Clin Psychopharmacol; 2005 Sep; 20(5):265-73. PubMed ID: 16096517
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.